On August 25th, Smoore Corporation’s Midyear Report posted it has earned about $564M revenues by the middle of the year, rose by 18.5% year-on-year growth. The report also showed that the mid-year profits were about $112M despite variation influence of fair value made by Pre-ipo investors applying Convertible Bond, and the business activities bring about $189M net profits for the company, with year-on-year growth of 40.4%.
For the 1st quarter 2020, Smoore gained profits of $185M. The second quarter witnessed explosive growth, with revenues of $378M, an increase of 104.2% over the first quarter.
In the future, Smoore will keep maintaining its advantages in atomize technology field by investigating basic knowledge in Basic Research Institute, Technology Center and Technology Industrialization Center and technologically doing research guided by new theories. It will further realize the application of large scale mass production and simultaneously improve production capacity and intellectual & automatic running standard. Besides, Smoore will expand and investigate the application of atomize technology in medical and health field by cooperating with some medical and research institutions and pharmaceuticals companies.